Intravitreal Injections with Vascular Endothelial Growth Factor Inhibitors: A Practical Approach [PDF]
Ophthalmology and Therapy, 2020 Intravitreal injections with vascular endothelial growth factor inhibitors constitute the most prevalent ophthalmic procedure in developed countries.
Yousif Subhi +2 more
exaly +4 more sources
Qualitative Factors Impacting Patients and Clinicians Regarding Intravitreal Injections for Retinal Disorders: A Scoping Review [PDF]
Clinical OphthalmologyAndrew Ly, Evan Harnick, Tanisha Jowsey, Amy Jean Bannatyne Faculty of Health Sciences & Medicine, Bond University, Gold Coast, QLD, AustraliaCorrespondence: Andrew Ly, Bond University 14 University Drive, Robina, Gold Coast, QLD, Australia, Tel +61 ...
Ly A, Harnick E, Jowsey T, Bannatyne AJ
doaj +4 more sources
Silicone oil droplets following intravitreal bevacizumab injections
American Journal of Ophthalmology Case Reports, 2018 Purpose: To report the transient resurgence of symptomatic silicone oil droplets following intravitreal bevacizumab injections. Observations: We report seven patients presenting with silicone oil droplets following intravitreal bevacizumab injections ...
Jea H. Yu +5 more
doaj +3 more sources
Central retinal vein occlusion following intravitreal injections: a case series highlighting multifactorial risk [PDF]
International Journal of Retina and VitreousIntroduction Intravitreal injections are standard treatment for various manifestations of age-related macular degeneration (AMD) but are associated with rare complications, including central retinal vein occlusion (CRVO).
Michael Antonietti +3 more
doaj +2 more sources
Endophthalmitis following intravitreal injections at a tertiary center: real-life data on incidence, risk factors, management strategies, and visual outcomes [PDF]
BMC OphthalmologyPurpose To investigate the incidence, contributing factors, management, and long-term outcomes of endophthalmitis following intravitreal injections performed in our clinic.
Sebile Comcali +10 more
doaj +2 more sources
Real-world incidence of endopthalmitis after intravitreal anti-VEGF injections in Korea: findings from the Common Data Model in ophthalmology [PDF]
Epidemiology and Health, 2021 OBJECTIVES The aim of this study was to evaluate the real-world incidence of endophthalmitis after intravitreal anti-vascular endothelial growth factor (VEGF) injections using data from the Observational Medical Outcomes Partnership (OMOP) Common Data ...
Yongseok Mun +15 more
doaj +1 more source
Clinical outcomes of intravitreal treatment for ocular toxoplasmosis: systematic review and meta-analysis [PDF]
Revista da Sociedade Brasileira de Medicina Tropical, 2023 Background: Ocular toxoplasmosis is the leading cause of infectious posterior uveitis worldwide, accounting for 30-50% of all cases in immunocompetent patients.
Lutiana Amaral de Melo +5 more
doaj +1 more source
Case Reports in Ophthalmology, 2021 Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) is essential for the treatment of macular diseases such as wet age-related macular degeneration and macular edema.
Atsuta Ozaki +5 more
doaj +1 more source
Intravitreal injections: past trends and future projections within a UK tertiary hospital
Eye, 2021 To describe past trends and future projections for the number of intravitreal injections being administered at a large tertiary hospital in London, United Kingdom.
R. Chopra +7 more
semanticscholar +1 more source